Login to Your Account



Week in Review


Monday, October 31, 2011

Financings

Bind Biosciences Inc. raised $47 million in a Series D round, with Rusnano joining the syndicate.

NewLink Genetics Corp. set terms for its planned $61 million initial public offering.

Selecta Biosciences Inc. raised $47 million in a Series D round, with Rusnano joining the syndicate.

Deals

Adolor Corp. is being acquired by Cubist Pharmaceuticals Inc. for $415 million.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription